Hyperalgesia Therapeutics- Pipeline Analysis 2018, Clinical Trials & Results

Hyperalgesia is a medical condition in which a person develops an increased sensitivity towards pain. There are several nerve pathways in the body where signals can start miscommunication with each other, resulting in hyperalgesia.

Download the sample report @ https://www.pharmaproff.com/request-sample/1100

Hyperalgesia can be categorized into several types which includes primary, secondary and opioid-induced hyperalgesia. The main symptom associated with the disease is increasing extreme reaction to painful stimuli without any new injury.

Get the sample report @ https://www.pharmaproff.com/report/hyperalgesia-therapeutics-pipeline-analysis

The disease can be treated with non-opioid medications, methadone, buprenorphine, and ketamine. Company like Rottapharm Biotech Srl is in the process of developing CRB0089 as an anti-TrkA therapeutic monoclonal antibody for the treatment of hyperalgesia.

Make enquiry before purchase @ https://www.pharmaproff.com/enquiry/1100

• The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials.
• Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.

About Us:

Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.

Contact:
Pharma Proff
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@pharmaproff.com

Web: https://www.pharmaproff.com

Connect with us on: LinkedIn | Twitter | Facebook